Postępy w Kardiologii Interwencyjnej

Full text

2/2026 vol. 22
Special paper

CREST-2 findings are unchanged using an aggregated control group for the CAS and CEA trial

Piotr Musialek 1, 2
,
Krzystof Malinowski 3, 4
,
Lukasz Tekieli 5
,
Horst Sievert 6
,
Anna Podlasek 7
,
Adam Mazurek 1, 2
,
Renata Hatalska-Żerebiec 8
,
Joachim Schofer 9
,
Panagiotis Papanagiotou 10, 11
,
Iris Q. Grunwald 12, 13

  1. Jagiellonian University Department of Cardiac and Vascular Diseases, Krakow, Poland

  2. St. John Paul II Hospital, Krakow, Poland

  3. Department of Bioinformatics and Telemedicine, Jagiellonian University Medical College, Krakow, Poland

  4. Center for Digital Medicine and Robotics, Jagiellonian University Medical College, Krakow, Poland

  5. Jagiellonian University Department of Interventional Cardiology, Krakow, Poland

  6. CardioVascular Center, Frankfurt, Germany

  7. Image-Guided Therapy Research Facility, University of Dundee, Dundee, UK

  8. University Department of Neurology with Stroke Unit, Holy Spirit Multispecialty Regional Hospital, Sandomierz, Poland

  9. MVZ-Department Structural Heart Disease, Asklepios Clinic/Klinik St Georg, Hamburg, Germany

  10. Department of Radiology, Aretaieion University Hospital, National and Kapodistrian University of Athens, Athens, Greece

  11. Klinik für Diagnostische und Interventionelle Neuroradiologie, Klinikum Bremen Mitte Bremen, Bremen, Germany

  12. Department of Radiology, Ninewells Hospital, Dundee, UK

  13. Chair of Neuroradiology, University of Dundee, Dundee, UK

Adv Interv Cardiol 2026; 22, 2 (84): 178–189

DOI: https://doi.org/10.5114/aic.2026.163187
Data publikacji online: 2026/07/09
Article file
CREST-2 findings.pdf
  1. Musialek P, Bonati LH, Bulbulia R, et al. Stroke risk management in carotid atherosclerotic disease: a Clinical Consensus Statement of the ESC Council on Stroke and the ESC Working Group on Aorta and Peripheral Vascular Diseases. Cardiovasc Res 2025; 121: 13-43.
  2. Boehme AK, Esenwa C, Elkind MS. Stroke risk factors, genetics, and prevention. Circ Res 2017; 120: 472-95.
  3. Spagnoli LG, Mauriello A, Sangiorgi G, et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 2004; 292: 1845-52.
  4. Musialek P, Rosenfield K, Siddiqui AH, et al. Carotid stenosis and stroke: medicines, stents, surgery – “wait-and-see” or protect? Thromb Haemost 2024; 124: 815-27.
  5. Tekieli L, Dzierwa K, Grunwald IQ, et al. Outcomes in acute carotid-related stroke eligible for mechanical reperfusion: SAFEGUARD-STROKE Registry. J Cardiovasc Surg 2024; 65: 231-48.
  6. Abbott AL. Procedural benefit for asymptomatic carotid stenosis is wishful thinking. J Vasc Surg 2021; 73: 1472-3.
  7. Derdeyn CP. Carotid stenting for asymptomatic carotid stenosis: trial it. Stroke 2007; 38 (2 Suppl): 715-20.
  8. Brott TG, Howard G, Lal BK, et al.; CREST-2 Investigators. Medical management and revascularization for asymptomatic carotid stenosis. N Engl J Med 2026; 394: 219-31.
  9. Meschia JF, Lal B, Brott T. CREST-2: Early reflections on the primary results. Semin Vasc Surg 2026; 39: 52-7.
  10. Hicks CW, Veith FJ, Perler BA. Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial-2 (CREST-2) and the contemporary management of asymptomatic carotid stenosis. Eur J Vasc Endovasc Surg 2026; 71: 534-6.
  11. AbuRahma A, Schermerhorn M, Calligaro K. Commentary by the Society for Vascular Surgery regarding Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial-2. J Vasc Surg 2026; 83: 971-3.
  12. Behrendt CA, Tulamo R, Venermo M. CREST-2 means crescendo? Eur J Vasc Endovasc Surg 2026; 71: 531-3.
  13. Calligaro KD, AbuRahma AF, Schermerhorn ML. Why CREST-2 Trial Results Should Inform, Not Replace, Clinical Judgment. https://medcitynews.com/2026/03/why-crest-2-trial-results-should-inform-not-replace-clinical-judgment (accessed 21 May 2026).
  14. Grotta JC. CREST-2: providing clarity on managing asymptomatic carotid stenosis. Stroke Vasc Interv Neurol 2026; 6: e002266.
  15. Guyot P, Ades AE, Ouwens MJ, et al. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol 2012; 12: 9.
  16. De Rosa S, Arcidiacono B, Chiefari E, et al. Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links. Front Endocrinol 2018; 9: 2.
  17. Magnussen C, Ojeda FM, Leong DP, et al.; Global Cardiovascular Risk Consortium. Global effect of modifiable risk factors on cardiovascular disease and mortality. N Engl J Med 2023; 389: 1273-85.
  18. GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 2024; 23: 973-1003.
  19. Howard DPJ, Gaziano L, Rothwell PM; Oxford Vascular Study. Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis. Lancet Neurol 2021; 20: 193-202.
  20. Musialek P, Hopf-Jensen S. Carotid artery revascularization for stroke prevention: a new era. J Endovasc Ther 2017; 24: 138-48.
  21. Weiner S, Benton MH, Guraziu B, et al. High stroke rate in patients with medically managed asymptomatic carotid stenosis at an Academic Center in the Southeastern United States. Ann Vasc Surg 2022; 85: 418-23.
  22. Rasoul S, Ottervanger JP, Dambrink JH, et al. External validity of ST elevation myocardial infarction trials: the Zwolle studies. Catheter Cardiovasc Interv 2007; 69: 632-6.
  23. Musialek P. TASTE-less endpoint of 30-day mortality (and some other issues with TASTE) in evaluating the effectiveness of thrombus aspiration in STEMI: not the “evidence” to change the current practice of routine consideration of manual thrombus extraction. Pol Heart J 2014; 72: 479-8.
  24. Abbott AL, Nederkoorn PJ. Outcomes are improving for patients with carotid stenosis. Neurology 2015; 85: 302-3.
  25. Brown MM, Bonati LH. Managing asymptomatic carotid stenosis. N Engl J Med 2026; 394: 296-7.
  26. Howard G, Meschia JF, Lal BK, et al. Design matters: challenges and remedies in CREST-2. Stroke 2026; 57: 1481-4.
  27. Social Security Administration. Actuarial life table. Accessed February 23, 2026. https://www.ssa.gov/oact/STATS/table4c6. html (accessed 21 May 2026).
  28. CREST-2 Shows Reduced Stroke Risk With Carotid Artery Stenting Plus Intensive Medical Management; No Added Benefit Seen With CEA. Endovascular Today, November 21, 2025. https://evtoday.com/news/crest-2-shows-reduced-stroke-risk-with-carotid-artery-stenting-no-added-benefit-seen-with-endarterectomy
  29. DeBakey ME. Successful carotid endarterectomy for cerebrovascular insufficiency. Nineteen-year follow-up. JAMA 1975; 233: 1083-5.
  30. Roubin GS, Yadav S, Iyer SS, et al. Carotid stent-supported angioplasty: a neurovascular intervention to prevent stroke. Am J Cardiol 1996; 78: 8-12.
  31. https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&NCAId=157 (accessed 21 May 2026).
  32. Columbo JA, Stone DH, Martinez-Camblor P, et al. Adoption and diffusion of transcarotid artery revascularization in contemporary practice. Circ Cardiovasc Interv 2023; 16: e012805.
  33. Jalbert JJ, Nguyen LL, Gerhard-Herman MD, et al. Comparative effectiveness of carotid artery stenting versus carotid endarterectomy among Medicare beneficiaries. Circ Cardiovasc Qual Outcomes 2016; 9: 275-85.
  34. Musialek P, de Donato G. Carotid artery revascularization using the endovascular route. In: Peripheral Arterial interventions: A Practical Guide. Ruzsa Z, Bartus S, Nemes B. Edizioni Minerva Medica, Torino 2023; 142-72.
  35. Caron E, Van Galen I, Darling JD, et al. Comparative outcomes of transfemoral carotid artery stenting versus carotid endarterectomy versus transcarotid artery revascularization in standard- and high-risk patients since the CMS decision in October 2023 using the VQI. J Vasc Surg 2026; 83: 100-11.
  36. Musialek P, Paraskevas KI, Roubin GS. Improving carotid artery stenting to match carotid endarterectomy: a task accomplished. EuroIntervention 2024; 20: e402-4.
  37. Stabile E, Salemme L, Sorropago G, et al. Proximal endovascular occlusion for carotid artery stenting: results from a prospective registry of 1,300 patients. J Am Coll Cardiol 2010; 55: 1661-7.
  38. Bijuklic K, Wandler A, Hazizi F, Schofer J. The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): a prospective randomized trial. J Am Coll Cardiol 2012; 59: 1383-9.
  39. Hornung M, Bertog SC, Franke J, et al. Evaluation of proximal protection devices during carotid artery stenting as the first choice for embolic protection. EuroIntervention 2015; 10: 1362-7.
  40. Stabile E, Sannino A, Schiattarella GG, et al. Cerebral embolic lesions detected with diffusion-weighted magnetic resonance imaging following carotid artery stenting: a meta-analysis of 8 studies comparing filter cerebral protection and proximal balloon occlusion. JACC Cardiovasc Interv 2014; 7: 1177-83.
  41. Schofer J, Musiałek P, Bijuklic K, et al. A prospective, multicenter study of a novel mesh-covered carotid stent: the CGuard CARENET Trial (Carotid Embolic Protection Using MicroNet). JACC Cardiovasc Interv 2015; 8: 1229-34.
  42. Musialek P, Mazurek A, Trystula M, et al. Novel PARADIGM in carotid revascularisation: Prospective evaluation of All-comer peRcutaneous cArotiD revascularisation in symptomatic and Increased-risk asymptomatic carotid artery stenosis using CGuard™ MicroNet-covered embolic prevention stent system. EuroIntervention 2016; 12: e658-70.
  43. Mazurek A, Borratynska A, Malinowski KP, et al. MicroNET-covered stents for embolic prevention in patients undergoing carotid revascularisation: twelve-month outcomes from the PARADIGM study. EuroIntervention 2020; 16: e950-2.
  44. Karpenko A, Bugurov S, Ignatenko P, et al. Randomized controlled trial of conventional versus MicroNet-covered stent in carotid artery revascularization. JACC Cardiovasc Interv 2021; 14: 2377-87.
  45. Sirignano P, Stabile E, Mansour W, et al. 1-month results from a prospective experience on CAS using CGuard Stent System: the IRONGUARD 2 Study. JACC Cardiovasc Interv 2020; 13: 2170-7.
  46. Speziale F, Capoccia L, Sirignano P, et al. Thirty-day results from prospective multi-specialty evaluation of carotid artery stenting using the CGuard MicroNet-covered Embolic Prevention System in real-world multicentre clinical practice: the IRON-Guard study. EuroIntervention 2018; 13: 1714-20.
  47. Sirignano P, Stabile E, Mansour W, et al. 1-year results from a prospective experience on CAS using the CGuard Stent System: the IRONGUARD 2 Study. JACC Cardiovasc Interv 2021; 14: 1917-23.
  48. Karpenko A, Bugurov S, Ignatenko P, et al. Randomized controlled trial of conventional versus MicroNet-covered stent in carotid artery revascularization: 12-month outcomes. JACC Cardiovasc Interv 2023; 16: 878-80.
  49. Pieniazek P, Musialek P, Kablak-Ziembicka A, et al. Carotid artery stenting with patient- and lesion-tailored selection of the neuroprotection system and stent type: early and 5-year results from a prospective academic registry of 535 consecutive procedures (TARGET-CAS). J Endovasc Ther 2008; 15: 249-62.
  50. Cremonesi A, Roffi M, Castriota F, et al. Carotid artery stenting. In: Windecker S, Byrne R, Capranzano P, eds. The 2025 PCR Textbook of Percutaneous Interventional Cardiovascular Medicine. PCRonline.com https://textbooks.pcronline.com/the-pcr-textbook/carotid-artery-stenting (accessed 21.05.2026).
  51. Mazurek A, Malinowski K, Rosenfield K, et al.; CARMEN (CArotid Revascularization Systematic Reviews and MEta-aNalyses) Investigators. Clinical outcomes of second- versus first-generation carotid stents: a systematic review and meta-analysis. J Clin Med 2022; 11: 4819.
  52. Mazurek A, Malinowski K, Sirignano P, et al.; (CArotid Revascularization systematic reviews and MEta-aNalyses (CARMEN) Collaborators. Carotid artery revascularization using second generation stents versus surgery: a meta-analysis of clinical outcomes. J Cardiovasc Surg 2023; 64: 570-82.
  53. Musiałek P, Hopkins LN, Siddiqui AH. One swallow does not a summer make but many swallows do: accumulating clinical evidence for nearly-eliminated peri-procedural and 30-day complications with mesh-covered stents transforms the carotid revascularisation field. Adv Interv Cardiol 2017; 13: 95-106.
  54. Metzger DC, Soukas P, Siddiqui A, et al.; (C-GUARDIANS Investigators). Safety and efficacy of a novel micro net carotid stent system: results of the C-GUARDIANS Trial. JACC Cardiovasc Interv 2025; 18: 3087-97.
  55. Musialek P, Mazurek A, Kolvenbach R, et al. 5-year clinical and ultrasound outcomes in CARENET prospective multicenter trial of CGuard MicroNET-covered carotid stent. JACC Cardiovasc Interv 2022; 15: 1889-91.
  56. Musialek P, Tekieli L, Umemoto T. Carotid Antiembolic (“Mesh”) stents: not created equal. J Soc Cardiovasc Angiogr Interv 2024; 3: 102429.
  57. Tekieli L, Afanasjev A, Mazgaj M, et al. A multi-center study of the MicroNET-covered stent in consecutive patients with acute carotid-related stroke: SAFEGUARD-STROKE. Adv Interv Cardiol 2024; 20: 172-93.
  58. Zidan M, Voss YL, Wolf M, et al. The dual-layer cguard stent is safe and effective in emergent carotid artery stenting and in tandem occlusions: a multi-centric study. Clin Neuroradiol 2025; 35: 77-85.
  59. Musialek P, Grunwald IQ, Siddiqui AH. ESC consensus statement on stroke risk management in carotid atherosclerotic disease: 10 key points. Eur Heart J 2025; 46: 4150-3.
  60. Dzierwa K, Kedziora A, Tekieli L, et al. Endovascular carotid revascularization under open-chest extracorporeal circulation combined with cardiac surgery in unstable patients at increased risk of carotid-related stroke: SIMultaneous urgent cardiac surgery and MicroNet-covered stent carotid revascularization in extreme-risk patients-SIMGUARD Study. J Cardiovasc Surg 2023; 64: 591-607.
  61. Abbott A. Asymptomatic carotid artery stenosis – it’s time to stop operating. Nat Clin Pract Neurol 2008; 4: 4-5.
  62. Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009; 40: e573-83.
  63. Abbott AL. Current medical intervention alone is now the best solution for asymptomatic carotid stenosis. Eur J Vasc Endovasc Surg 2010; 40: 678-9.
  64. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004; 351: 1493-501.
  65. Reiff T, Eckstein HH, Mansmann U, et al. Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis: 5-year results of a multicentre, randomised controlled trial. Lancet Neurol 2022; 21: 877-88.
  66. Eckstein HH, Reiff T, Ringleb P, et al. SPACE-2: a missed opportunity to compare carotid endarterectomy, carotid stenting, and best medical treatment in patients with asymptomatic carotid stenoses. Eur J Vasc Endovasc Surg 2016; 51: 761-5.
  67. Donners SJA, van Velzen TJ, Cheng SF, et al. Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trial. Lancet Neurol 2025; 24: 389-99.
  68. Brott TG, Hobson RW 2nd, Howard G, et al.; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010; 363: 11-23.
  69. [SCAI – Society for Cardiovascular Angiography and Interventions]. Results of the CREST-2 Trial: Medical Therapy and Revascularization for Asymptomatic Carotid Stenosis. https://www.scai.org/results-crest-2-trial-medical-therapy-and-revascularization-asymptomatic-carotid-stenosis (accessed 21 May 2026).
  70. Blackshear JL, Cutlip DE, Roubin GS, et al.; CREST Investigators. Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation 2011; 123: 2571-8.
  71. Jones MR, Howard G, Roubin GS, et al.; CREST Investigators. Periprocedural stroke and myocardial infarction as risks for long-term mortality in CREST. Circ Cardiovasc Qual Outcomes 2018; 11: e004663.
  72. Chimowitz MI. Design matters: how methodological decisions may have shaped the findings of CREST-2. Stroke 2026; 57: 1476-80.
  73. Wu WW, Liang P, O’Donnell TFX, et al. Anatomic eligibility for transcarotid artery revascularization and transfemoral carotid artery stenting. J Vasc Surg 2019; 69: 1452-60.
  74. Kokkosis AA, Macdonald S, Jim J, et al. Assessing the suitability of the carotid bifurcation for stenting: anatomic and morphologic considerations. J Vasc Surg 2021; 74: 2087-95.
  75. Bulbulia R, Halliday A. Carotid stenting: the myth of real world evidence versus the magic of randomisation. Eur J Vasc Endovasc Surg 2024; 67: 97-8.
  76. Sabatine MS, Giugliano RP, Keech AC, et al.; FOURIER Steering Committee and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 2017; 376: 1713-22.
  77. Head SJ, Kaul S, Mack MJ, et al. The rationale for heart team decision-making for patients with stable, complex coronary artery disease. Eur Heart J 2013; 34: 2510-8.
  78. Podlasek A, Grunwald IQ, Musiałek P. The evolution from an “average” study patient to patient-specific characteristics to guide interventions in vascular medicine. Pol Arch Intern Med 2021; 131: 5-8.
  79. Musialek P, Tracz W, Tekieli L, et al. Multimarker approach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosis. J Clin Neurol 2013; 9: 165-75.
  80. Kamtchum-Tatuene J, Noubiap JJ, Wilman AH, et al. Prevalence of high-risk plaques and risk of stroke in patients with asymptomatic carotid stenosis: a meta-analysis. JAMA Neurol 2020; 77: 1524-35.
  81. Musialek P, Tekieli L Podlasek A. Carotid plaque characteristics and stroke risks: more questions – or more answers? Pol Heart J 2025; 83: 257-9.
  82. Paraskevas KI, Musialek P, Lip GYH, Chaturvedi S. Selective screening for asymptomatic carotid artery stenosis: an appraisal of the 2024 European Society of Cardiology (ESC) guidelines position. Am J Med 2025; 138: 209-11.
  83. Musialek P. Carotid stenting following CREST-2: how to democratize – and do MicroNET stents and TCAR have a role? In: Clinical conference proceedings of the 18th Biennial Meeting of the International Andreas Gruentzig Society. J Invasive Cardiol 2026 (in press).
  84. Grunwald IQ, Mathias K, Bertog S, et al. World Federation for Interventional Stroke Treatment (WIST) multispecialty training guidelines for endovascular stroke intervention. Adv Interv Cardiol 2023; 19: 6-13.
  85. Grunwald IQ, Musialek P, Podlasek A, et al.; WIST guidelines author group. World Federation for Interventional Stroke Treatment (WIST) multispecialty training guidelines for endovascular stroke intervention: Time is brain! Response to commentary by UKNG. Clin Radiol 2024; 79: e637-9.
  86. Song P, Fang Z, Wang H, Cai Y, et al. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health 2020; 8: 721-9.
  87. Samson K. Carotid surgery may be unnecessary for asymptomatic stenosis patients. Neurology Today 2020; 20: 13-9.
  88. Bagatin A. CREST-2: New evidence in asymptomatic carotid-artery stenosis management. https://www.escardio.org/communities/councils/stroke/scientific-documents-and-publications/heart-and-stroke-blog/crest-2-new-evidence-in-asymptomatic-carotid-artery-stenosis-management (accessed 21 May 2026).
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Indexed in
pubmed
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications